MALAT1 and type 2 diabetes mellitus: Additionally, the AUC of Oment-1 combined with MALAT1 was 0.771 (95% CI: 0.694–0.848; p < 0.001), the sensitivity was 66.7%, the specificity was 75.3%, the PPV was 73.3%, and the NPV was 69.1%, indicating that the combination of Oment-1 and MALAT1 had better diagnostic value for CHD in T2DM patients.